Innate immunity as the trigger of systemic autoimmune diseases

Autoimmune Disease

Common innate pathways to autoimmune disease

Clin Immunol.

Langan D, Moudgil KD, Rose NR

doi: 10.1016/j.clim.2020.108361.

Autoimmune Disease

Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases

Front Immunol.

Carnero-Montoro E, Barturen G, Povedano E, Kerick M, Martinez-Bueno M, PRECISESADS Clinical Consortium., Ballestar E, Martin J, Teruel M, Alarcón-Riquelme ME

doi: 10.3389/fimmu.2019.01880.

Autoimmune Disease

Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy

Rheumatology (Oxford).

Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Le Tiec C, Descamps E, Seror R, Mariette X

doi: 10.1093/rheumatology/kez430.

PsoriasisRheumatoid Arthritis

Survivin in autoimmune diseases

Autoimmun Rev.

Gravina G, Wasén C, Garcia-Bonete MJ, Turkkila M, Erlandsson MC, Töyrä Silfverswärd S, Brisslert M, Pullerits R, Andersson KM, Katona G, Bokarewa MI

doi: 10.1016/j.autrev.2017.05.016.

Further Publications Immunology

Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?

Ann Rheum Dis.

Baker KF, Isaacs JD

doi: 10.1136/

Systemic Lupus Erythematosus

Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

Front Immunol.

Herrada AA, Escobedo N, Iruretagoyena M, Valenzuela RA, Burgos PI, Cuitino L, Llanos C

doi: 10.3389/fimmu.

Autoimmune Disease

Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

J Autoimmun.

Marziale A, Bettacchioli E, Picart G, Nafai S, Galinat H, Meroni PL, Frostegard J, PRECISESADS Clinical Consortium., Alarcon-Riquelme ME, Renaudineau Y

doi: 10.1016/j.jaut.2020.102524.

T Cells

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Allergy.

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Boyman O, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol EF, Kolios A, Levi-Schaffer F, Nocentini G, Palomares O, Redegeld F, Van Esch B, Stellato C

doi: 10.1111/all.14478.

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms

J Autoimmun.

Alexander T, Farge D, Badoglio M, Lindsay JO, Muraro PA, Snowden JA, Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

doi: 10.1016/j.jaut.2018.06.002.

Related content

Common innate pathways to autoimmune disease

Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases

Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy

Survivin in autoimmune diseases

Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?

Innate Immune Cells' Contribution to Systemic Lupus Erythematosus

Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases

Immune modulation via T regulatory cell enhancement: disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases - An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)

Hematopoietic stem cell therapy for autoimmune diseases - Clinical experience and mechanisms